Bile duct adenoma
Bile duct adenoma is a benign liver lesion characterized composed of bile duct epithelium.
It is also known as a benign bile duct proliferation.
- Important as it can be misdiagnosed as cancer.
- Disordered bile ducts within in a fibrotic stroma.
- No (yellow) bile within, as these lesions do not have a connection to the biliary tree.
- +/-Lymphocytic cuff.
- No mitotic activity.
- No necrosis.
- Metastatic adenocarcinoma.
- Bile duct hamartoma (von Meyenburg complex).
- Bile duct adenoma (ganfyd.org).
- Bile duct adenoma (surgpath4u.com).
- Bile duct adenoma - oncocytic - low mag. (nih.gov).
- Bile duct adenoma - oncocytic - high mag. (nih.gov).
Bile duct adenoma in a 67 yo man, not radiologically detected; this is important because cholangiocarcinomas are larger than bile duct adenomas. Bile duct adenomas are usually incidental findings, as in this case. These can be very difficult diagnosis; this case was evaluated by outside consultation. A. Glandular proliferation is seen. Note the curve indicated by the arrow, indicating a subcapsular location. B. The central scar, in other locations and with metastases, a finding associated with carcinoma, is in the liver a benign sign. The intense hyalin is also a benign sign, being that of a well-developed adenoma. C. Nuclear atypia in this case is modest near the region of scar, with tortuous glands. D. As the lesion progresses away from the scar, the atypia diminishes. Mitoses and outright necrosis were not identified. E. PAS-D stain shows the red rims about the glands, a benign sign, but also red cytoplasmic droplets, which is consistent with bile duct adenoma’s being known to produce mucin.
- CK7 +ve.
- HepPar-1 -ve.
- Ki-67 low.
- p53 -ve.
- mCEA -ve.
- Johannesen, EJ.; Wu, Z.; Holly, JS. (2014). "Bile duct adenoma with oncocytic features.". Case Rep Pathol 2014: 282010. doi:10.1155/2014/282010. PMID 24592348.
- URL: http://www.surgpath4u.com/caseviewer.php?case_no=152. Accessed on: 6 March 2014.
- Hornick, JL.; Lauwers, GY.; Odze, RD. (Mar 2005). "Immunohistochemistry can help distinguish metastatic pancreatic adenocarcinomas from bile duct adenomas and hamartomas of the liver.". Am J Surg Pathol 29 (3): 381-9. PMID 15725808.